Innovation Theater Breakfast: Trusted Science. New Format. Expanded Impact. Clinical Benefits of Pure Hypochlorous Acid in Gel Form (non-accredited/non-approved for CECH)

Modern wound care continues to present significant clinical challenges, including rapid bioburden reformation, pH imbalance, incomplete or inadequate debridement, and the escalating concern of antimicrobial resistance. These factors often complicate wound bed preparation and delay healing progression.
This session introduces a newly available hypochlorous acid gel designed to address these challenges through sustained activity and extended contact time at the wound surface. Compared to traditional solution formats, the gel provides prolonged antimicrobial activity, wound acidification, and debridement while remaining in place to support an optimal healing environment.
Insights from a newly published multidisciplinary expert panel review will be presented, highlighting real-world clinical experiences from physicians and nurse practitioners who evaluated the gel’s advantages, limitations, and potential role in both acute and chronic wound management. The discussion will place the gel within the broader context of available topical therapies, acknowledging the strengths and trade-offs of each approach.
Through evidence-based clinical case reviews across diverse wound types and care settings, this presentation will demonstrate how one trusted hypochlorous acid solution—now available in a sustained gel format—can streamline protocols, reduce unnecessary product layering, and support effective, accessible healing outcomes.
A new era in primary wound care is here!
Sponsored by Urgo Medical North America.